世界の医療美容市場は、2024年に895.5億米ドルと評価されており、2035年までに2,219.2億米ドルに達すると予想され、予測期間（2024年〜2035年）の年間平均成長率（CAGR）は8.6％で拡大すると見込まれています。医療美容に対する意識は、発展途上国および先進国の両方で急速に高まっており、世界の医療美容業界に前例のない変革をもたらしています。人々は初めて、美容の向上だけでなく、自己信頼や加齢に関するウェルネスの理想のために美容施術を求めるようになっています。このため、クリニック、メディスパ、皮膚科チェーンは、科学、芸術、そして先端医療技術の応用を組み合わせた顧客向け調査の多様化を進めています。これらの施設では、注入療法、レーザー治療、ボディコンターリング、最小侵襲の外科的介入などの施術が提供され、手頃な価格と社会的受容性の向上により普及しています。
患者は非侵襲的な方法を好む傾向が増しており、消費者は迅速な回復、短いダウンタイム、自然な仕上がりを求めています。一方で、一部の患者は、劇的で長持ちする効果を得るために侵襲的な手法を好む場合もあります。こうした二つの成長パターンにより、医療機器メーカーや製薬会社は、効果と安全性、そして患者の快適性のバランスを追求しながら、絶えずイノベーションを行っています。さらに、AIを活用した診断ツールや個別化治療マッピングによるデジタル化は、この分野の成長軌道にさらなる価値を加えています。
この市場は、大胆な製品投入、戦略的提携、革新的なエネルギー機器、再生医療、先進的注入剤に関する研究開発への強力な投資による競争環境で特徴付けられています。規制圧力と技術的高度化により、ステークホルダーはイノベーション戦略の見直しと安全基準のベンチマーキングを迫られています。人口が高齢化し、ミレニアル世代が美容予防ケアに支出を増やすにつれて、医療美容業界にとって最も収益性の高い時代が訪れています。
AbbVie Inc., Lumenis Ltd., Cutera Inc., Cynosure LLC, Alma Lasers, Evolus Inc., Candela Corporation, Bausch Health Companies Inc., Revance Therapeutics Inc., Allergan Aesthetics
市場は2024年の895.5億米ドルから2035年に2,219.2億米ドルに成長し、CAGRは8.6％と予測されます。非侵襲施術の普及、技術革新、医療観光の拡大が成長を牽引します。
目次
Chapter 1. Market Snapshot
1.1. Market Definition & Report Overview
1.2. Market Segmentation
1.3. Key Takeaways
1.3.1. Top Investment Pockets
1.3.2. Top Winning Strategies
1.3.3. Market Indicators Analysis
1.3.4. Top Impacting Factors
1.4. Application Ecosystem Analysis
1.4.1. 360’ Analysis
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Market Attractiveness Analysis (top leader’s point of view on the market)
2.5. Key Findings
Chapter 3. Research Methodology
3.1. Research Objective
3.2. Supply Side Analysis
3.2.1. Primary Research
3.2.2. Secondary Research
3.3. Demand Side Analysis
3.3.1. Primary Research
3.3.2. Secondary Research
3.4. Forecasting Models
3.4.1. Assumptions
3.4.2. Forecasts Parameters
3.5. Competitive breakdown
3.5.1. Market Positioning
3.5.2. Competitive Strength
3.6. Scope of the Study
3.6.1. Research Assumption
3.6.2. Inclusion & Exclusion
3.6.3. Limitations
Chapter 4. Industry Landscape
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Porter’s 5 Forces Model
4.2.1. Bargaining Power of Buyer
4.2.2. Bargaining Power of Supplier
4.2.3. Threat of New Entrants
4.2.4. Threat of Substitutes
4.2.5. Competitive Rivalry
4.3. Value Chain Analysis
4.4. PESTEL Analysis
4.5. Pricing Analysis and Trends
4.6. Key growth factors and trends analysis
4.7. Market Share Analysis (2024)
4.8. Top Winning Strategies (2024)
4.9. Trade Data Analysis (Import Export)
4.10. Regulatory Guidelines
4.11. Historical Data Analysis
4.12. Analyst Recommendation & Conclusion
Chapter 5. Global Medical Aesthetics Market Size & Forecasts by Procedure Type 2024-2035
5.1. Market Overview
5.1.1. Market Size and Forecast By Procedure Type 2024-2035
5.2. Invasive Procedures
5.2.1. Breast augmentation
5.2.2. Liposuction
5.2.3. Nose reshaping
5.2.4. Eyelid Surgery
5.2.5. Tummy tuck
5.2.6. Others
5.3. Non-invasive Procedures
5.3.1. Botox injections
5.3.2. Soft tissue fillers
5.3.3. Chemical peel
5.3.4. Laser hair removal
5.3.5. Microdermabrasion
5.3.6. Others
Chapter 6. Global Matting Agents Market Size & Forecasts by End Use 2024-2035
6.1. Market Overview
6.1.1. Market Size and Forecast By End Use 2024-2035
6.2. Hospitals
6.2.1. Market definition, current market trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2024-2035
6.2.3. Market share analysis, by country, 2024-2035
6.3. Clinics & Aesthetic Centers
6.3.1. Market definition, current market trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2024-2035
6.3.3. Market share analysis, by country, 2024-2035
6.4. Medspas
6.4.1. Market definition, current market trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2024-2035
6.4.3. Market share analysis, by country, 2024-2035
Chapter 7. Global Matting Agents Market Size & Forecasts by Type of Device 2024-2035
7.1. Market Overview
7.1.1. Market Size and Forecast By Type of Device 2024-2035
7.2. Standalone Devices
7.2.1. Market definition, current market trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2024-2035
7.2.3. Market share analysis, by country, 2024-2035
7.3. Multimodal Devices
7.3.1. Market definition, current market trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2024-2035
7.3.3. Market share analysis, by country, 2024-2035
7.4. At-Home/Self-Use Devices
7.4.1. Market definition, current market trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2024-2035
7.4.3. Market share analysis, by country, 2024-2035
Chapter 8. Global Medical Aesthetics Market Size & Forecasts by Region 2024-2035
8.1. Regional Overview 2024-2035
8.2. Top Leading and Emerging Nations
8.3. North America Medical Aesthetics Market
8.3.1. U.S. Medical Aesthetics Market
8.3.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.1.2. End Use breakdown size & forecasts, 2024-2035
8.3.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.3.2. Canada Medical Aesthetics Market
8.3.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.2.2. End Use breakdown size & forecasts, 2024-2035
8.3.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.3.3. Mexico Medical Aesthetics Market
8.3.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.3.3.2. End Use breakdown size & forecasts, 2024-2035
8.3.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.4. Europe Medical Aesthetics Market
8.4.1. UK Medical Aesthetics Market
8.4.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.1.2. End Use breakdown size & forecasts, 2024-2035
8.4.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.2. Germany Medical Aesthetics Market
8.4.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.2.2. End Use breakdown size & forecasts, 2024-2035
8.4.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.3. France Medical Aesthetics Market
8.4.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.3.2. End Use breakdown size & forecasts, 2024-2035
8.4.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.4. Spain Medical Aesthetics Market
8.4.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.4.2. End Use breakdown size & forecasts, 2024-2035
8.4.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.5. Italy Medical Aesthetics Market
8.4.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.5.2. End Use breakdown size & forecasts, 2024-2035
8.4.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.4.6. Rest of Europe Medical Aesthetics Market
8.4.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.4.6.2. End Use breakdown size & forecasts, 2024-2035
8.4.6.3. Type of Device breakdown size & forecasts, 2024-2035
8.5. Asia Pacific Medical Aesthetics Market
8.5.1. China Medical Aesthetics Market
8.5.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.1.2. End Use breakdown size & forecasts, 2024-2035
8.5.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.2. India Medical Aesthetics Market
8.5.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.2.2. End Use breakdown size & forecasts, 2024-2035
8.5.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.3. Japan Medical Aesthetics Market
8.5.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.3.2. End Use breakdown size & forecasts, 2024-2035
8.5.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.4. Australia Medical Aesthetics Market
8.5.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.4.2. End Use breakdown size & forecasts, 2024-2035
8.5.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.5. South Korea Medical Aesthetics Market
8.5.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.5.2. End Use breakdown size & forecasts, 2024-2035
8.5.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.5.6. Rest of APAC Medical Aesthetics Market
8.5.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.5.6.2. End Use breakdown size & forecasts, 2024-2035
8.5.6.3. Type of Device breakdown size & forecasts, 2024-2035
8.6. LAMEA Medical Aesthetics Market
8.6.1. Brazil Medical Aesthetics Market
8.6.1.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.1.2. End Use breakdown size & forecasts, 2024-2035
8.6.1.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.2. Argentina Medical Aesthetics Market
8.6.2.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.2.2. End Use breakdown size & forecasts, 2024-2035
8.6.2.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.3. UAE Medical Aesthetics Market
8.6.3.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.3.2. End Use breakdown size & forecasts, 2024-2035
8.6.3.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.4. Saudi Arabia (KSA Medical Aesthetics Market
8.6.4.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.4.2. End Use breakdown size & forecasts, 2024-2035
8.6.4.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.5. Africa Medical Aesthetics Market
8.6.5.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.5.2. End Use breakdown size & forecasts, 2024-2035
8.6.5.3. Type of Device breakdown size & forecasts, 2024-2035
8.6.6. Rest of LAMEA Medical Aesthetics Market
8.6.6.1. Procedure Type breakdown size & forecasts, 2024-2035
8.6.6.2. End Use breakdown size & forecasts, 2024-2035
8.6.6.3. Type of Device breakdown size & forecasts, 2024-2035
Chapter 9. Company Profiles
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Company Overview
9.2.1.2. Key Executives
9.2.1.3. Company Snapshot
9.2.1.4. Financial Performance (Subject to Data Availability)
9.2.1.5. Product/Services Port
9.2.1.6. Recent Development
9.2.1.7. Market Strategies
9.2.1.8. SWOT Analysis
9.2.2. Lumenis Ltd.
9.2.3. Cutera Inc.
9.2.4. Cynosure LLC
9.2.5. Alma Lasers
9.2.6. Evolus Inc.
9.2.7. Candela Corporation
9.2.8. Bausch Health Companies Inc.
9.2.9. Revance Therapeutics Inc.
9.2.10. Allergan Aesthetics
